NeonMind Biosciences Inc(TSE:LCR)
CA$0.010.00 (0.00%)
TSE:LCR
NeonMind Biosciences Inc financials statements
CA$0.01
At close:0.00 (0.00%)
Want to see TSE:LCR full AI Analyst Report?
NeonMind Biosciences Inc (LCR) Ratios
15 Followers
NeonMind Biosciences Inc Ratios
TSE:LCR's free cash flow for Q1 2026 was C$168.04K. For the 2026 fiscal year, TSE:LCR's free cash flow was increased by C$0.00 and operating cash flow was C$168.04K. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Mar 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.40 | 0.03 | 0.21 | 0.19 | 2.14 |
| Quick Ratio | 0.40 | 0.03 | 0.16 | 0.19 | 2.14 |
| Cash Ratio | 0.25 | 0.00 | 0.04 | 0.05 | 1.29 |
| Solvency Ratio | -1.00 | -0.77 | -0.00 | -1.33 | -6.87 |
| Operating Cash Flow Ratio | -1.45 | -0.04 | -0.85 | -1.58 | -9.72 |
| Short-Term Operating Cash Flow Coverage | -13.60 | -0.08 | -1.09 | 0.00 | 0.00 |
| Net Current Asset Value | C$ -1.47M | C$ -1.95M | C$ -1.05M | C$ -1.40M | C$ 230.10K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.04 | 13.10 | 1.44 | 6.54 | 0.34 |
| Debt-to-Equity Ratio | -1.79 | -0.63 | -1.69 | -0.60 | 1.55 |
| Debt-to-Capital Ratio | 2.27 | -1.68 | 2.44 | -1.53 | 0.61 |
| Long-Term Debt-to-Capital Ratio | 2.49 | -1.68 | 2.44 | -1.53 | 0.61 |
| Financial Leverage Ratio | -1.72 | -0.05 | -1.17 | -0.09 | 4.61 |
| Debt Service Coverage Ratio | -6.14 | -0.00 | -0.00 | -7.26 | -249.19 |
| Interest Coverage Ratio | -7.24 | -6.81 | 0.00 | -6.27 | -234.19 |
| Debt to Market Cap | 0.19 | 2737.97 | 1.02 | 3.65 | 2.23 |
| Interest Debt Per Share | 0.01 | 24.24 | 0.02 | 1.00 | 0.49 |
| Net Debt to EBITDA | -0.61 | -1330.46 | -4331772348228173824.00 | -0.46 | 0.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.61% | 99.11% | 100.00% | 100.00% | 107.83% |
| EBT Per EBIT | 132.15% | 145.56% | 212.70% | 116.16% | 85.36% |
| Return on Assets (ROA) | -160.50% | -1684.68% | -0.50% | -1571.78% | -538.23% |
| Return on Equity (ROE) | 275.95% | 80.67% | 0.59% | 145.10% | -2482.82% |
| Return on Capital Employed (ROCE) | -324.73% | 55.82% | 0.28% | 315.53% | -1057.75% |
| Return on Invested Capital (ROIC) | -275.84% | 130.96% | -0.40% | 566.92% | -1057.75% |
| Return on Tangible Assets | -160.50% | -1684.68% | -0.50% | -1571.78% | -538.23% |
| Earnings Yield | -29.35% | -183757.38% | -0.18% | -876.96% | -3575.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -1.61 | -0.03 | -0.96 | -5.92 |
| Free Cash Flow Per Share | -0.01 | -1.61 | -0.03 | -1.08 | -5.92 |
| Dividend Paid and CapEx Coverage Ratio | -247164.00 | -26.79 | -6.49 | -7.89 | -1721.16 |
| Capital Expenditure Coverage Ratio | -247164.00 | -26.79 | -6.49 | -7.89 | -1721.16 |
| Operating Cash Flow Coverage Ratio | -0.87 | -0.08 | -1.09 | -1.28 | -12.94 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -16.56% | -10748.21% | -64.37% | -524.99% | -2889.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.35 | -0.54 | -562.10 | -0.11 | -0.03 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -9.40 | -0.00 | -3.31 | -0.17 | 0.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.04 | -0.01 | -1.55 | -0.19 | -0.03 |
| Price-to-Operating Cash Flow Ratio | -6.04 | -0.01 | -1.79 | -0.21 | -0.03 |
| Price-to-Earnings Growth (PEG) Ratio | 0.31 | 0.01 | 5.88 | 0.00 | -0.00 |
| Enterprise Value Multiple | -4.40 | -1331.39 | -13252462028095750144.00 | -0.60 | 0.02 |
| Enterprise Value | 6.93M | 1.19M | 3.01M | 1.04M | -121.94K |
| EV to EBITDA | -4.40 | -1331.39 | -13252462028095750144.00 | -0.60 | 0.02 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -7.01 | -13.30 | -2.31 | -0.86 | 0.02 |
| EV to Operating Cash Flow | -7.01 | -13.30 | -2.66 | -0.97 | 0.02 |
| Tangible Book Value Per Share | -0.01 | -34.23 | -0.01 | -1.24 | 0.30 |
| Shareholders’ Equity Per Share | -0.01 | -34.17 | -0.01 | -1.24 | 0.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.14 | -0.08 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -27.56 | -0.00 | -1.80 | -7.33 |
| Tax Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.08 |
| Interest Burden | 1.12 | 1189.62 | 2.13 | 1.16 | 0.85 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.57 | 0.06 | 0.31 | 0.53 | 0.87 |
Currency in CAD
